ARS Pharmaceuticals Launches neffy in Schools Program
ARS Pharmaceuticals, a dedicated biopharmaceutical company, has announced an exciting new initiative aimed at enhancing emergency care in K-12 schools across the United States. This program is designed to provide eligible public and private schools with free access to neffy, a needle-free epinephrine nasal spray, which can be crucial for managing severe allergic reactions, especially anaphylaxis. The program is set to kick off in the near future, promoting both safety and accessibility in schools.
Understanding the Importance of neffy
With the alarming statistics related to Type I allergic reactions among children, the need for immediate access to effective treatment has never been more critical. Research indicates that approximately 18% of children with food allergies have experienced allergic reactions at school. Unfortunately, many of these reactions occur in students who have not been previously diagnosed with allergies. This highlights the importance of having emergency treatments like neffy readily available on school premises.
What is neffy?
neffy is a revolutionary intranasal formulation of epinephrine, indicated for emergency treatment of Type I allergic reactions, including anaphylaxis. It is specifically designed for adults and children who weigh over 30 kg (66 lbs). By offering an alternative to traditional auto-injectors, neffy addresses some of the common barriers associated with epinephrine administration, such as fear of needles and disposal challenges.
Program Details and Eligibility
The neffy in Schools program aims to eliminate costs for schools, making it easier for them to stock essential emergency medications. Participating schools will receive two cartons of neffy, which contains four single-use doses. In instances where the medication is used or reaches its expiration date, schools will have the ability to obtain replacements, ensuring continuous support for students in need.
Engaging with Schools
Before the launch of this program, it is crucial for school administrators to familiarize themselves with both federal and state regulations regarding epinephrine stocking. Currently, legislation exists in 49 states and Washington DC, allowing schools to store epinephrine. This proactive step not only empowers schools but also enhances student safety.
Training and Resources for Implementation
Alongside the provision of neffy, ARS Pharmaceuticals plans to support schools with training resources designed for school nurses and administrators. A dedicated webinar will offer detailed insights into the proper use of neffy as well as guidance on managing allergic emergencies effectively. After the official launch, additional instructions will be provided to simplify the process for schools accessing neffy doses.
Safety and Effectiveness of neffy
The efficacy of neffy in providing immediate intervention during allergic reactions cannot be understated. Due to its needle-free nature, it minimizes safety concerns associated with needles, making it more accessible for young patients and those who may be anxious about injections. With a shelf life of 30 months, neffy is designed to remain effective for extended periods, contributing to better preparedness in schools.
About ARS Pharmaceuticals
ARS Pharmaceuticals has made it its mission to empower patients and caregivers to protect against severe allergic reactions. By commercializing neffy, the company aims to make critical treatment readily available, especially in environments frequented by children. As an innovative biopharmaceutical company, ARS is continuously seeking to solve challenges presented by allergic conditions.
Frequently Asked Questions
1. What is the neffy in Schools program?
The neffy in Schools program provides free cartons of neffy to eligible K-12 schools, offering life-saving treatment for allergy emergencies.
2. Who qualifies for receiving neffy under this program?
Eligible public and private K-12 schools in the U.S. can apply for the neffy program.
3. What are the benefits of using neffy?
neffy is a needle-free epinephrine spray, making it easier and safer for administration in emergency situations.
4. How will schools receive training for using neffy?
ARS Pharmaceuticals will provide training through webinars and additional resources for school nurses and administrators.
5. What should schools check before implementing the program?
Schools are encouraged to review local regulations to ensure compliance with laws governing epinephrine stocking and administration.
